Leukotriene-receptor antagonists
- 1 January 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 353 (9146) , 57-62
- https://doi.org/10.1016/s0140-6736(98)09019-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonistJournal of Allergy and Clinical Immunology, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.Journal of Clinical Investigation, 1998
- ZafirlukastDrugs, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.Journal of Clinical Investigation, 1997
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase InhibitorNew England Journal of Medicine, 1990
- Leukotrienes are potent constrictors of human bronchiNature, 1980